The TRIUMPH phase III development program is evaluating the safety and efficacy of retatrutide for chronic weight management, obstructive sleep apnea (OSA), and knee osteoarthritis (OA) in people with obesity and overweight
Additional testing includes stability assessment under defined storage and handling conditions
The General Pharmaceutical Council issued a public warning that non-medicinal, unregulated, unlicensed products like Lemon Bottle have potentially caused serious harm, and reminded pharmacies that unlicensed products carry limited or no clinical safety data
Side effects are usually mild and may include nausea or gastrointestinal discomfort, which typically subsides after the first few weeks of treatment
For anyone with a heart condition, like myself (as I've shared in my Lemon8 Diary posts), it's extra important to communicate any unusual feelings with your doctor